One of Maryland's largest drug manufacturers is suing the federal government to fend off competition on one of its key drugs, saying its right to exclusively sell the medication should continue an additional three years.
A decade ago, physicians who treat epilepsy got what seemed like a piece of good news: Eight companies had received federal approval to sell a generic version of an injectable lifesaving drug.
Organizations in the United Kingdom could be fined up to £17m ($22.06m), or 4 percent of their global turnover, for having poor cybersecurity under proposed new laws.
Even as regulators at home and abroad block deals, Chinese acquirers will spend $1.5tr buying companies abroad in the next decade, 70 percent more than the previous 10 years, Linklaters LLP said in a recent report.
A federal court handed climate change advocates a narrow loss last week when it tossed an Obama-era ruling to phase out hydrofluorocarbons (HFCs) used in refrigeration and air conditioning.
South Korea's Hanjin Shipping Co., which roiled global trade and temporarily marooned more than half a million cargo containers when it filed for bankruptcy, says it has raised only a fraction of what it needs to repay creditors, whose claims total about $10.5bn.